Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/12/2003US6605271 Activating cell proliferation and differentiation in hematopoietic cells; obtain cells, incubate with modulator, monitor cell propagation
08/12/2003US6605222 Separation and purification of antihemophilic factors from blood using ion exchangers
08/12/2003US6605115 Method and composition for inhibiting cardiovascular cell proliferation
08/12/2003CA2116888C Human anti-tnf antibodies
08/08/2003CA2417305A1 Method of affecting sleep & sleep-related behaviours
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065045A2 Diagnostics and therapeutics for diseases associated with the gpr65 receptor
08/07/2003WO2003065010A2 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis
08/07/2003WO2003064992A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064677A2 Long-acting follicle stimulating hormone analogues and uses thereof
08/07/2003WO2003064676A2 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064654A1 Human serine/threonine protein kinase
08/07/2003WO2003064651A2 Regulation of human membrane-type serine protease
08/07/2003WO2003064647A1 Method of controlling circadian rhythm
08/07/2003WO2003064646A1 Novel peptide and use thereof
08/07/2003WO2003064642A1 Regulation of human thymidylate kinase
08/07/2003WO2003064639A1 Regulation of human mitogen-activate protein kinase catalytic domain
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064628A2 Novel proteins and nucleic acids encoding same
08/07/2003WO2003064620A2 Hepsin substrates and prodrugs
08/07/2003WO2003064616A2 Compounds and methods for inducing growth arrest and apoptosis
08/07/2003WO2003064614A2 Transport peptides and uses therefor
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064607A2 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
08/07/2003WO2003064603A2 Nucleic acid molecule encoding iwu-1
08/07/2003WO2003064602A2 Methods of modulating cold sensory perception
08/07/2003WO2003064599A2 Cancer genes
08/07/2003WO2003064593A2 Antigen panels and methods of using the same
08/07/2003WO2003064589A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064587A2 Hif-1 alpha proteins mutated in the c-terminal transactivation domain
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064466A1 Variants of the alpha 1 subunit of human ampk
08/07/2003WO2003064464A1 Tolerogenic peptides from myelin basic protein
08/07/2003WO2003064463A2 Pluripotency determining factors and uses thereof
08/07/2003WO2003064462A1 Peg-binding pth or peg-binding pth derivative
08/07/2003WO2003064461A1 Novel anti-viral vsf protein and hybridoma producing the same
08/07/2003WO2003064460A2 Two gonadotropin releasing hormones and a method to isolate the same
08/07/2003WO2003064458A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064456A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
08/07/2003WO2003064455A2 Macrocyclic peptides active against the hepatitis c virus
08/07/2003WO2003064454A1 Fap-activated anti-tumor compounds
08/07/2003WO2003064453A2 Trojan inhibitors, method for the production and use thereof
08/07/2003WO2003064452A2 Method for the preparation of highly branched polypeptides
08/07/2003WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
08/07/2003WO2003064449A2 Bioactive keratin peptides
08/07/2003WO2003064448A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064441A2 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064402A1 Treatment of male sexual dysfunction
08/07/2003WO2003063924A1 Medical device for delivering biologically active material
08/07/2003WO2003063911A1 Decoy-containing pharmaceutical compositions and method of using the same
08/07/2003WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER
08/07/2003WO2003063907A1 Drugs ameliorating circadian rhythum disorder
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063904A2 Tissue adhesion formation control
08/07/2003WO2003063903A2 Modulation of t lymphocytes using dp iv inhibitors
08/07/2003WO2003063898A2 Method of treating pain with botulinum toxin
08/07/2003WO2003063895A1 Treatment of bacterial infection with elastase
08/07/2003WO2003063894A1 Insulin resistance improving agents
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063892A1 Use of apelin
08/07/2003WO2003063891A1 Compositions and methods for modulating connexin hemichannels
08/07/2003WO2003063890A1 Troponin anti-metastatic therapeutic and method of use
08/07/2003WO2003063889A1 METHODS OF MODULATING β CELL FUNCTION
08/07/2003WO2003063888A1 Antiviral compositions and methods for identification and use
08/07/2003WO2003063887A1 Compositions and method of inhibiting bacterial spore germination
08/07/2003WO2003063886A1 Helicobacter pylori adhesion inhibitor
08/07/2003WO2003063870A1 A combination treatment for acute myocardial infarction
08/07/2003WO2003063869A1 Anti-viral compounds
08/07/2003WO2003063868A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
08/07/2003WO2003063841A1 Cyclosporin-containing sustained release pharmaceutical composition
08/07/2003WO2003063834A1 Multi-stage oral drug controlled-release system
08/07/2003WO2003063799A2 Compositions and methods for systemic inhibition of cartilage degradation
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063788A2 PTPase INHIBITORS AND METHODS OF USING THE SAME
08/07/2003WO2003063786A2 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
08/07/2003WO2003063785A2 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
08/07/2003WO2003063782A2 Kappa-pviia-related conotoxins as organ protectants
08/07/2003WO2003063780A2 Therapeutic composition for treatment of cancer by arginine depletion
08/07/2003WO2003063778A2 Reducing cholesterol with hydrolyzed whey protein
08/07/2003WO2003063775A2 Methods and compositions for the promotion of hair growth utilizing actin binding peptides
08/07/2003WO2003063769A2 Vesicle-associated proteins
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063760A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
08/07/2003WO2003063759A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
08/07/2003WO2003063688A2 Protein modification and maintenance molecules
08/07/2003WO2003063608A1 A process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
08/07/2003WO2003063593A1 Methods for treating cancer by administering tumor-targetted bacteria and an immunomodulatory agent
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003052091A8 Growth factor modified protein matrices for tissue engineering
08/07/2003WO2003048375B1 Hybrid glycosylated products and their production and use
08/07/2003WO2003046132A3 Antisense modulation of myd88 expression
08/07/2003WO2003035002B1 Management of postoperative pain
1 ... 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 ... 3163